Bristol-Myers Squibb Co., of New York, named Francis Cuss executive vice president and chief scientific officer, effective July 1...EntreMed Inc., of Rockville, Md., appointed Ken K. Ren CEO, and added James Huang and Y. Alexander Wu to its board

Prosensa Therapeutics BV, of Leiden, the Netherlands, named Larry Bell vice president of regulatory affairs...Protea Biosciences Inc., of Morgantown, W. Va., added Thijs Spoor and Josiah T. Austin to its board...Soligenix Inc., of Princeton, N.J., appointed Stephen T. Sonis, Dorothy Keefe and Mark Schubert to its newly created medical advisory board, which will deal with SGX942, its treatment for oral mucositis

Galectin Therapeutics Inc., of Norcross, Ga., named Rex Horton executive director of regulatory affairs and quality assurance...Probiodrug AG, of Halle, Germany, appointed Ronald Black chief medical officer and Inge Lues chief development officer...Rexahn Pharmaceuticals Inc., of Rockville, Md., named Peter D. Suzdak CEO and Chang AHN chief scientist

Pharmalink AB, of Stockholm, Sweden, named Heather Cook director of regulatory affairs and Marek Poszepczynski director of business development...Pharmanest AB, of Stockholm, Sweden, added Per Lango and Gunilla Ekstrom to its board, and named Alan Raffensperger board chairman

Cerecor Inc., of Baltimore, appointed James Vornov senior vice president, clinical development and regulatory affairs, and John Kaiser vice president of commercialization and business development

Sunesis Pharmaceuticals Inc., of South San Francisco, appointed Deborah A. Thomas vice president, regulatory affairs, and Gene C. Jamieson vice president, chemistry, manufacturing and controls...Zyngenia Inc., of Gaithersburg, Md., added Christian Itin and Jason Rhodes to its board

Eli Lilly and Co., of Indianapolis, named Michael Harrington senior vice president and general counsel...VacInnate Corp., of Cranbury, N.J., appointed Christine Mayer vice president of business development and Katalin Abraham vice president of regulatory affairs

Mark Oki senior vice president, finance and chief financial officer...and Edwin Kamemoto vice president, regulatory affairs

Arena Pharmaceuticals Inc., of San Diego, named Craig Audet senior vice president, operations and head of global regulatory affairs...Xenetic Biosciences plc, of London, added Subash Kapre and Thomas Ulich to its scientific advisory board

XenoPort Inc., of Santa Clara, Calif., appointed Vincent Angotti executive vice president, chief operating officer, and named Gregory Bates senior vice president, regulatory affairs and quality

Oncobiologics Inc., of Cranbury, N.J., appointed Stephen McAndrew vice president, business development and Vincent Benn vice president, clinical and regulatory affairs...Paratek Pharmaceuticals Inc., of Boston, appointed Dennis Molnar CEO and director and Evan Loh chief medical officer and board chairman

PolyTherics Ltd., of London, added Anker Lundemose and Nigel Pitchford to its board...Synthetic Biologics Inc., of Ann Arbor, Mich., appointed Jeffrey Kraws independent chairman of the board and Carol Reed senior vice president of clinical and regulatory affairs

Galena Biopharma Inc., of Lake Oswego, Ore., named Rosemary Mazanet executive vice president and chief medical officer and appointed Robert Figlin to its scientific advisory board...Novo Nordisk Inc., of Bagsvaerd, Denmark, appointed Robert Clark vice president, regulatory affairs

Threshold Pharmaceuticals Inc., of South San Francisco, appointed Robert Simon senior vice president of regulatory affairs...XOMA Corp., of Berkeley, Calif., named Paul Rubin senior vice president, research and development

AcelRx Pharmaceuticals Inc., of Redwood City, Calif., named Kim Gaumer vice president, regulatory affairs and quality assurance...Array BioPharma Inc., of Boulder, Colo., appointed Howard Holden vice president of regulatory affairs and quality assurance...Avion Pharmaceuticals LLC, of Atlanta, appointed Michael Sullivan vice president, sales and marketing

CombiMatrix Corp., of Irvine, Calif., appointed Richard Ding and Joseph Limber to its board...and Christine Mikail, executive vice president, corporate development, general counsel and secretary

Sangart Inc., of San Diego, promoted Frank Booth to chief medical officer, added Mary Rose Keller as vice president of clinical operations and named Carmen Betancourt-Riche vice president of regulatory affairs and quality assurance...Tobira Therapeutics Inc., of South San Francisco, appointed Eric Lefebvre chief medical officer and named Martine Kraus vice president of regulatory affairs

George M. Gill will return to his previous role of senior vice president of regulatory affairs and also has been appointed chief safety officer...Pernix Therapeutics Holdings Inc., of The Woodlands, Texas, appointed David Becker chief financial officer, Charles "Chuck" Hrushka vice president of sales and marketing and Leslie White director of regulatory affairs and quality assurance

George M. Gill will return to his previous role of senior vice president of regulatory affairs and also has been appointed chief safety officer...Pernix Therapeutics Holdings Inc., of The Woodlands, Texas, appointed David Becker chief financial officer, Charles "Chuck" Hrushka vice president of sales and marketing and Leslie White director of regulatory affairs and quality assurance